Global Radiopharmaceuticals in Nuclear Medicine Sales Market Report 2019

Table of Contents

Global Radiopharmaceuticals in Nuclear Medicine Sales Market Report 2017
1 Radiopharmaceuticals in Nuclear Medicine Market Overview
1.1 Product Overview and Scope of Radiopharmaceuticals in Nuclear Medicine
1.2 Classification of Radiopharmaceuticals in Nuclear Medicine by Product Category
1.2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Diagnostic Radiopharmaceuticals
1.2.4 Therapy Radiopharmaceuticals
1.2.5 Enriched Stable Isotopes
1.3 Global Radiopharmaceuticals in Nuclear Medicine Market by Application/End Users
1.3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Other
1.4 Global Radiopharmaceuticals in Nuclear Medicine Market by Region
1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2022)
1.4.3 China Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2022)
1.4.4 Europe Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2022)
1.4.5 Japan Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2022)
1.4.6 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2022)
1.4.7 India Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Radiopharmaceuticals in Nuclear Medicine (2012-2022)
1.5.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2022)
1.5.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2012-2022)

2 Global Radiopharmaceuticals in Nuclear Medicine Competition by Players/Suppliers, Type and Application
2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Competition by Players/Suppliers
2.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Radiopharmaceuticals in Nuclear Medicine (Volume and Value) by Type
2.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Type (2012-2017)
2.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Type (2012-2017)
2.3 Global Radiopharmaceuticals in Nuclear Medicine (Volume and Value) by Region
2.3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Region (2012-2017)
2.3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Region (2012-2017)
2.4 Global Radiopharmaceuticals in Nuclear Medicine (Volume) by Application

3 United States Radiopharmaceuticals in Nuclear Medicine (Volume, Value and Sales Price)
3.1 United States Radiopharmaceuticals in Nuclear Medicine Sales and Value (2012-2017)
3.1.1 United States Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
3.1.2 United States Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2012-2017)
3.1.3 United States Radiopharmaceuticals in Nuclear Medicine Sales Price Trend (2012-2017)
3.2 United States Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Players
3.3 United States Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Type
3.4 United States Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Application

4 China Radiopharmaceuticals in Nuclear Medicine (Volume, Value and Sales Price)
4.1 China Radiopharmaceuticals in Nuclear Medicine Sales and Value (2012-2017)
4.1.1 China Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
4.1.2 China Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2012-2017)
4.1.3 China Radiopharmaceuticals in Nuclear Medicine Sales Price Trend (2012-2017)
4.2 China Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Players
4.3 China Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Type
4.4 China Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Application

5 Europe Radiopharmaceuticals in Nuclear Medicine (Volume, Value and Sales Price)
5.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Value (2012-2017)
5.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
5.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2012-2017)
5.1.3 Europe Radiopharmaceuticals in Nuclear Medicine Sales Price Trend (2012-2017)
5.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Players
5.3 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Type
5.4 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Application

6 Japan Radiopharmaceuticals in Nuclear Medicine (Volume, Value and Sales Price)
6.1 Japan Radiopharmaceuticals in Nuclear Medicine Sales and Value (2012-2017)
6.1.1 Japan Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
6.1.2 Japan Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2012-2017)
6.1.3 Japan Radiopharmaceuticals in Nuclear Medicine Sales Price Trend (2012-2017)
6.2 Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Players
6.3 Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Type
6.4 Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Application

7 Southeast Asia Radiopharmaceuticals in Nuclear Medicine (Volume, Value and Sales Price)
7.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales and Value (2012-2017)
7.1.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Price Trend (2012-2017)
7.2 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Players
7.3 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Type
7.4 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Application

8 India Radiopharmaceuticals in Nuclear Medicine (Volume, Value and Sales Price)
8.1 India Radiopharmaceuticals in Nuclear Medicine Sales and Value (2012-2017)
8.1.1 India Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
8.1.2 India Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2012-2017)
8.1.3 India Radiopharmaceuticals in Nuclear Medicine Sales Price Trend (2012-2017)
8.2 India Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Players
8.3 India Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Type
8.4 India Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share by Application

9 Global Radiopharmaceuticals in Nuclear Medicine Players/Suppliers Profiles and Sales Data
9.1 Bracco Imaging S.P.A.
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Cambridge Isotope Laboratories, Inc.
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Cardinal Health, Inc.
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Covidien, Plc
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Eczacibasi-Monrol
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Fujifilm Holdings Corporation
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 GE Healthcare (Subsidiary Of General Electric Company)
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 IBA Group
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Isotec, Inc. (Sigma-Aldrich)
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Lantheus Medical Imaging, Inc.
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Nordion, Inc.
9.12 Ntp Radioisotopes (Pty), Ltd.
9.13 Siemens Healthcare (Subsidiary Of Siemens AG)
9.14 Taiyo Nippon Sanso Corporation
9.15 Urenco Limited
9.16 Rotem Industries, Ltd., Inc.
9.17 Australian Nuclear Association And Technology Organization (ANSTO)
9.18 Board of Radiation And Isotope Technology (BRIT)
9.19 Institute of Atomic Energy Polatom Radioisotope Centre
9.20 Institute of Isotopes Co., Ltd.
9.21 Institute Of Radioelement (IRE)

10 Radiopharmaceuticals in Nuclear Medicine Maufacturing Cost Analysis
10.1 Radiopharmaceuticals in Nuclear Medicine Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
10.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast (2017-2022)
14.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Radiopharmaceuticals in Nuclear Medicine Price and Trend Forecast (2017-2022)
14.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Type (2017-2022)
14.3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Type (2017-2022)
14.3.3 Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Type (2017-2022)
14.4 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Radiopharmaceuticals in Nuclear Medicine
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type (Product Category) in 2016
Figure Diagnostic Radiopharmaceuticals Product Picture
Figure Therapy Radiopharmaceuticals Product Picture
Figure Enriched Stable Isotopes Product Picture
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Application in 2016
Figure Diagnostic Application Examples
Table Key Downstream Customer in Diagnostic Application
Figure Therapeutic Application Examples
Table Key Downstream Customer in Therapeutic Application
Figure Research Examples
Table Key Downstream Customer in Research
Figure Pharmaceutical Examples
Table Key Downstream Customer in Pharmaceutical
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Size (Million USD) by Regions (2012-2022)
Figure United States Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Radiopharmaceuticals in Nuclear Medicine Sales Share by Players/Suppliers
Figure 2017 Radiopharmaceuticals in Nuclear Medicine Sales Share by Players/Suppliers
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Players
Table 2017 Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Players
Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share by Type (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Type (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate by Type (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Radiopharmaceuticals in Nuclear Medicine by Type (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate by Type (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Region (2012-2017)
Figure Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Region (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate by Region in 2016
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Radiopharmaceuticals in Nuclear Medicine by Region (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate by Region in 2016
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Radiopharmaceuticals in Nuclear Medicine by Region (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region in 2016
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Application (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2012-2017)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure United States Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Players (2012-2017)
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Players (2012-2017)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Players in 2016
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Type (2012-2017)
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type (2012-2017)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type in 2016
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Application (2012-2017)
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Application (2012-2017)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Application in 2016
Figure China Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure China Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Radiopharmaceuticals in Nuclear Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table China Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Players (2012-2017)
Table China Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Players (2012-2017)
Figure China Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Players in 2016
Table China Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Type (2012-2017)
Table China Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type (2012-2017)
Figure China Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type in 2016
Table China Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Application (2012-2017)
Table China Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Application (2012-2017)
Figure China Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Application in 2016
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Players (2012-2017)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Players (2012-2017)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Players in 2016
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Type (2012-2017)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type (2012-2017)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type in 2016
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Application (2012-2017)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Application (2012-2017)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Application in 2016
Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Players (2012-2017)
Table Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Players (2012-2017)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Players in 2016
Table Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Type (2012-2017)
Table Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type (2012-2017)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type in 2016
Table Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Application (2012-2017)
Table Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Application (2012-2017)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Application in 2016
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Players in 2016
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type in 2016
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Application in 2016
Figure India Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure India Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Radiopharmaceuticals in Nuclear Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table India Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Players (2012-2017)
Table India Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Players (2012-2017)
Figure India Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Players in 2016
Table India Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Type (2012-2017)
Table India Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type (2012-2017)
Figure India Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type in 2016
Table India Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Application (2012-2017)
Table India Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Application (2012-2017)
Figure India Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Application in 2016
Table Bracco Imaging S.P.A. Basic Information List
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (2012-2017
Figure Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Revenue Global Market Share (2012-2017)
Table Cambridge Isotope Laboratories, Inc. Basic Information List
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (2012-2017
Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Revenue Global Market Share (2012-2017)
Table Cardinal Health, Inc. Basic Information List
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (2012-2017
Figure Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Revenue Global Market Share (2012-2017)
Table Covidien, Plc Basic Information List
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (2012-2017
Figure Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Revenue Global Market Share (2012-2017)
Table Eczacibasi-Monrol Basic Information List
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (2012-2017
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Revenue Global Market Share (2012-2017)
Table Fujifilm Holdings Corporation Basic Information List
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (2012-2017
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Revenue Global Market Share (2012-2017)
Table GE Healthcare (Subsidiary Of General Electric Company) Basic Information List
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (2012-2017
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Revenue Global Market Share (2012-2017)
Table IBA Group Basic Information List
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure IBA Group Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure IBA Group Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (2012-2017
Figure IBA Group Radiopharmaceuticals in Nuclear Medicine Revenue Global Market Share (2012-2017)
Table Isotec, Inc. (Sigma-Aldrich) Basic Information List
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (2012-2017
Figure Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Revenue Global Market Share (2012-2017)
Table Lantheus Medical Imaging, Inc. Basic Information List
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Global Market Share (2012-2017
Figure Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Revenue Global Market Share (2012-2017)
Table Nordion, Inc. Basic Information List
Table Ntp Radioisotopes (Pty), Ltd. Basic Information List
Table Siemens Healthcare (Subsidiary Of Siemens AG) Basic Information List
Table Taiyo Nippon Sanso Corporation Basic Information List
Table Urenco Limited Basic Information List
Table Rotem Industries, Ltd., Inc. Basic Information List
Table Australian Nuclear Association And Technology Organization (ANSTO) Basic Information List
Table Board of Radiation And Isotope Technology (BRIT) Basic Information List
Table Institute of Atomic Energy Polatom Radioisotope Centre Basic Information List
Table Institute of Isotopes Co., Ltd. Basic Information List
Table Institute Of Radioelement (IRE) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Radiopharmaceuticals in Nuclear Medicine
Figure Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
Figure Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
Table Raw Materials Sources of Radiopharmaceuticals in Nuclear Medicine Major Players in 2016
Table Major Buyers of Radiopharmaceuticals in Nuclear Medicine
Table Distributors/Traders List
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share Forecast by Regions in 2022
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Regions in 2022
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) Forecast by Type (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Type (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) Forecast by Application (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources